Document:

Exhibit 10.8

 

INHIBIKASE
THERAPEUTICS, INC.

 

EMPLOYMENT
AGREEMENT

 

This EMPLOYMENT AGREEMENT
(hereinafter referred to as this “Agreement”) is dated October 24, 2018, with the intent that it be effective
as of and from the Effective Date (defined below), by and between INHIBIKASE THERAPEUTICS (the “Company”), and
Joseph Frattaroli (the “Employee”).

 

WHEREAS, the parties
hereto wish to enter into an employment agreement to employ the Employee as Chief Financial Officer.

 

NOW, THEREFORE, in
consideration of the mutual covenants and representations contained herein, the parties hereto agree as follows:

 

1.           
Employment Period. The Company will employ the Employee, and the Employee will serve the Company,
under the terms of this Agreement, commencing on and contingent upon the closing of the initial public offering of the Company’s
common stock (the “Effective Date”) and continuing until terminated in accordance with Section 4 below.
The period of time between the Effective Date and the termination of the Employee’s employment hereunder shall be referred
to herein as the “Employment Period.”

 

2.            
Duties and Status.

 

A.          
Position. The Company hereby engages the Employee as Chief Financial Officer on the terms and conditions set
forth in this Agreement. During the Employment Period, the Employee’s principal job duties and job responsibilities will
include, but may not be limited to, the following:

 

		·	Responsible for all required filings with the Securities and Exchange Commission

		·	Responsible for acquiring and maintaining an accounting system and practice to meet the requirements of GAAP and Federal regulations
under FAR and DFAR

		·	Responsible for managing all accounting activities and obligations of the Company

		·	Engagement with investors and banking underwriters and stakeholders

 

In addition, the Employee
shall assist the Company with such other matters specified by senior management and shall exercise such other duties, responsibilities
and authority consistent with Employee’s training, experience and position as the Company shall direct from time to time.
Employee agrees to devote all of his or her business time, efforts and skills to the performance of his or her duties and responsibilities
under this Agreement. Because working for other companies or otherwise engaging in activities for pay would constitute a potential
distraction or conflict of interest, Employee agrees not to provide any services to any other company or person, whether as an
employee, consultant, or independent contractor, while employed by the Company, without notice to and the prior written approval
of the Company. Employee may engage in volunteer, charitable, educational, religious and similar types of activities to the extent
such activities do not prohibit, prevent or interfere with the performance of the Employee’s duties under this Agreement
or conflict in any way with the business of the Company or any of its affiliates.

 

     

     

    

 

B.           
Standard of Care. The Employee agrees to carry out his or her duties hereunder in a diligent, prudent and
professional manner consistent with his or her fiduciary duties as an employee of the Company.

 

3.           
Compensation and Benefits.

 

A.         
Base Salary. During the Employment Period, the Company shall pay to the Employee, as compensation for the
performance of his or her duties and obligations under this Agreement, a base salary at the rate of $375,000 per annum (the “Base
Salary”), payable in equal installments in accordance with the normal payroll practices of the Company. The Base Salary
may be modified in writing from time to time at the discretion of the Company.

 

B.          
Bonus. The Employee shall be eligible for a discretionary annual target bonus (an “Annual Bonus”)
at the sole discretion of the Company equal to 30% of Base Salary (the “Target Bonus”). The Annual Bonus is
not a wage and, other than as set forth in Section 5, payment of a cash bonus is expressly conditioned upon the Employee
being actually employed by the Company on the date such Annual Bonus is paid. Each Annual Bonus, if any, will be settled no later
than March 15 of the year following the year in respect of which it was earned.

 

C.          
Business Expenses. During the Employment Period, the Company shall promptly reimburse the Employee for all
reasonable out-of-pocket business expenses, including reasonable travel expenses and client entertainment in connection with Company
business, incurred by the Employee in the performance of his or her duties under this Agreement subject to the receipt of the Company’s
written consent prior to the incurrence of any single expense in excess of $1,000 (or related expenses in excess of such amount),
and upon submission of such documentation as may be required by the Company.

 

D.          
Benefits. During the Employment Period, the Employee is entitled to any group benefits, including medical
insurance, dental insurance, life insurance, and pension plans that the Company does or may provide to similarly-situated employees,
in each case subject to and on a basis consistent with the terms, conditions, and overall administration of such plans.

 

E.           
Paid Time Off. During each year during the Employment Period, Employee shall be entitled to 20 days of Paid
Time Off (“PTO”) in accordance with the policies of the Company in effect from time to time. PTO can be used
at Employee’s discretion for vacations, personal leave, or additional sick leave. PTO is accrued at a rate of 1.667 days
per month worked. PTO accrual is capped at 1.5 times the number of PTO days per year. For example, if Employee receives 20 days
of PTO per year, accrual is capped at 30 days. Once Employee has 30 days of accrued, unused PTO, no more PTO will accrue until
the balance falls below the cap. Accrued, unused PTO will be paid out upon termination of employment.

 

F.           
Paid Sick Leave. Employee will be eligible for paid sick leave under the Massachusetts Earned Sick Time Law
(“Earned Sick Time”). All 40 hours of Earned Sick Time are fully accrued on January 1 of each calendar year
and unused time cannot be carried over to future years. For 2018, Employee will receive 20 hours of accrued Earned Sick Time on
the Effective Date.

 

    -2-

     

    

 

G.           
Equity Grants.

 

(i)                
Initial Stock Option Grants. As soon as practicable following the Effective Date, the Employee will be granted
a stock option to purchase One Hundred Thousand (100,000) shares of Company common stock, pursuant to the Company’s nonqualified
stock option agreement under the Company’s 2011 Equity Incentive Plan or a successor thereto (the “Plan”). One-third
of the grant shall vest and become exercisable on the first anniversary of the Effective Date, and the remaining portion will vest
and become exercisable in 24 equal monthly installments commencing on the first day of the month following the first anniversary
of the Effective Date, subject to the Employee’s continued employment through each such vesting date.

 

(ii)               
Subsequent Equity Grants. In its sole discretion, the Board may grant to the Employee from time to time stock
options to purchase shares of Company common stock or such other equity awards as it may determine.

 

4.           
Termination of Employment.

 

A.         
Termination Without Cause. The Company may terminate the Employee’s employment hereunder without Cause
at any time without providing advance notice to the Employee.

 

B.          
Termination for Cause. The Company may terminate the Employee’s employment hereunder for Cause at any
time. The Company is not required to provide advance notice of termination to the Employee, except in the case of clauses (iv)
and (vii) below. For purposes of this Agreement and subject to the Employee’s opportunity to cure as provided below, the
Company shall have “Cause” to terminate the Employee’s employment hereunder if such termination shall
be the result of:

 

(i)                
commission of an act of disloyalty, dishonesty, breach of trust, fraud, misconduct, bad faith, embezzlement, misappropriation
or improper diversion of funds or assets of the Company, or destruction of Company property;

 

(ii)               
gross negligence in connection with the performance of the Employee’s duties hereunder;

 

(iii)              
the refusal, failure or willful nonfeasance by the Employee to perform his or her duties hereunder;

 

(iv)              
failure to comply with the policies of the Company, which the Employee does not cure within fifteen (15) days of a written
notice of act or omission giving rise to the application of this provision;

 

(v)               
conduct which is materially detrimental to the reputation, goodwill or business operations of the Company or any of its
affiliates;

 

    -3-

     

    

 

(vi)              
the conviction for, or plea of nolo contendere, to a charge of commission of a felony; or

 

(vii)             
the breach or violation of any other provision of this Agreement, which the Employee does not cure within fifteen (15) days
of a written notice of such breach or violation.

 

C.           
Termination Upon Death or Disability. The Employment Period shall be terminated by the death of the Employee.
The Employment Period may be terminated by the Company if, in the reasonable judgment of the Company, the Employee shall be rendered
incapable of performing his or her duties to the Company by reason of any physical or mental impairment that can be expected to
result in death or that can be expected to last for a period of three (3) or more consecutive months from the first date of the
Employee’s absence due to the disability or for a period of 120 non-consecutive days within any 365 day period (in either
case, a “Disability”). If the Employment Period is terminated by reason of Disability of the Employee, the Company
shall provide thirty (30) days’ advance written notice to that effect to the Employee.

 

D.           
Resignation; Notice Period. The Employee shall not retire, resign or otherwise terminate his or her employment,
except as provided under Section 4.E (a “Resignation”) with the Company for any reason without first giving
thirty (30) days prior written notice of the effective date of his or her Resignation (the “Required Notice”).
Such written notice shall be delivered by hand to the Chief Executive Officer. The thirty (30) days between the giving of the Required
Notice and the effective date of the Resignation, inclusive, is the “Notice Period.”

 

(i)                
The Company retains the right to waive the Required Notice in whole or in part, in which case the termination date shall
be the date that the Company accepts Employee’s resignation.

 

(ii)               
During the Notice Period, the Company may, in its sole discretion, take any one or more of the following actions: (a) require
the Employee to perform his or her normal duties and responsibilities; (b) require the Employee to remain away from the Company’s
premises; (c) require the Employee not to perform any duties on behalf of the Company; (d) require the Employee not to contact
clients, prospects, or managers of the Company; and/or (e) withdraw any powers vested in, or duties assigned to, the Employee.

 

(iii)               
The Company will continue to pay the Base Salary during the Notice Period only if the Employee is in compliance with his
or her obligations under this Agreement or otherwise to the Company during the Notice Period.

 

(iv)               
In the event that the Employee does not provide the Required Notice, the Employee acknowledges and agrees that such failure
to provide the Required Notice (a) constitutes a breach of this Agreement, and therefore constitutes a Cause event, and (b) subjects
the Company to irreparable harm entitling it to immediate or other equitable relief, including obtaining injunctive relief prohibiting
the Employee from commencing new employment or performing services for another employer or entity.

 

E.           
Termination for Good Reason by Employee following a Change in Control. The Employee may terminate his or her
Employment Period with Good Reason within twelve (12) months following a Change in Control.

 

    -4-

     

    

 

1.                 
“Good Reason” means the occurrence of any of the following conditions without the Employee’s express written
consent:

 

(a)              
A material diminution in the Employee’s authority, duties or responsibilities in effect immediately prior to such
diminution;

 

(b)              
A material diminution in the Employee’s base salary that persists for longer than 12 months; or

 

(c)              
Any other action or inaction that constitutes a material breach by the Company of this Agreement.

 

The Employee may not
terminate his or her Employment Period with Good Reason unless the Employee has provided the Company notice of Good Reason within
ninety (90) days of the initial existence of one or more of the above conditions, and the Company has had at least thirty (30)
days in which to remedy the condition. In the event the Company does not remedy the condition within such period, the Employee
must terminate his or her Employment Period with Good Reason no later than one hundred eighty (180) days following the initial
existence of one or more of the above conditions.

 

2.                 
“Change in Control” will mean the occurrence of any of the following events:

 

(a)              
The consummation by the Company of a merger or consolidation of the Company with any other corporation, other than a merger
or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50%
of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately
after such merger or consolidation;

 

(b)              
The approval by the stockholders of the Company, or if stockholder approval is not required, approval by the Board, of either
(1) a plan of complete liquidation of the Company or (2) an agreement for the sale or disposition by the Company of all or substantially
all of the Company’s assets; or

 

(c)              
Any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended)
becoming the “beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of
the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities.

 

Notwithstanding the
foregoing, a Change in Control will not be deemed to have occurred unless such event would also be a change in the ownership or
effective control of the Company, or in the ownership of a substantial portion of the Company’s assets, under Section 409A
of the Internal Revenue Code of 1986, as amended (the “Code”) or would otherwise be a permitted payment event
under Code Section 409A.

 

    -5-

     

    

 

5.           
Consequences of Termination and Resignation.

 

A.          
Termination Without Cause. In the event the Employee’s employment by the Company is terminated during
the Employment Period as a result of the Employee’s termination by the Company without Cause, and such termination does not
occur within the twelve (12) months following a Change in Control, then neither the Employee nor the Employee’s beneficiaries
or estate will have any further rights or claims against the Company under this Agreement except, subject to compliance with Section
6, Section 7 and Section 8, the right to receive: (i) any unpaid portion of the base salary provided for in Section
3.A, paid through the date of the Employee’s termination; (ii) reimbursement for any expenses for which the Employee
shall not have theretofore been reimbursed as provided in Section 3 hereof; and (iii) subject to Section 5.F below,
(w) payment of the Annual Bonus accrued for the year prior to such termination (to the extent not already paid), (x) payment of
the Employee’s annual bonus for the year of such termination, to the extent the Employee would have received such bonus had
the Employee remained employed through the applicable payment date of such bonus, appropriately pro-rated based on the number of
days that the Employee was employed by the Company during the year of the termination, paid when the Company’s other senior
executive receive payment of their annual bonuses, (y) severance pay in the amount of 9 months base salary, payable in equal installments
in accordance with the Company’s normal payroll practices, and (z) reimbursement for the difference between the cost of COBRA
and the employee’s contribution for health continuation coverage for 9 months following termination of employment, or if
sooner, until the Employee becomes covered under similar plans. Notwithstanding the foregoing, the Company shall provide no further
payments or benefits unless otherwise required by applicable law if the Employee breaches any of the covenants of this Agreement
that survive termination, including, without limitation, the non-competition covenant set forth in Section 6, the non-solicitation
covenant set forth in Section 7 and the confidentiality covenant in Section 8.

 

B.          
Termination Without Cause or with Good Reason following a Change in Control. In the event the Employee’s
employment by the Company is terminated during the Employment Period as a result of the Employee’s termination by the Company
without Cause or the Employee’s resignation with Good Reason, and such termination occurs within the twelve (12) months following
a Change in Control, neither the Employee nor the Employee’s beneficiaries or estate will have any further rights or claims
against the Company under this Agreement except, subject to compliance with Section 6, Section 7 and Section 8, the right to receive:
(i) any unpaid portion of the base salary provided for in Section 3.A, paid through the date of the Employee’s termination;
(ii) reimbursement for any expenses for which the Employee shall not have theretofore been reimbursed as provided in Section 3
hereof; and (iii) subject to Section 5.F below, (1) severance pay in the aggregate amount of 12 months base salary, paid in a lump
sum; (2) (x) payment of the Annual Bonus accrued for the year prior to such termination (to the extent not already paid), (y) the
Employee’s then-current Target Bonus pro-rated based on the number of days that the Employee was employed by the Company
during the year of the termination, and (z) one time the Employee’s then-current Target Bonus; (3) full vesting with respect
to the Employee’s then outstanding, unvested equity awards; and (4) reimbursement for the difference between the cost of
COBRA and the employee’s contribution for health continuation coverage for 12 months following termination of employment,
or if sooner, until the Employee becomes covered under similar plans. Notwithstanding the foregoing, the Company shall provide
no further payments or benefits unless otherwise required by applicable law if the Employee breaches any of the covenants of this
Agreement that survive termination, including, without limitation, the non-competition covenant set forth in Section 6,
the non-solicitation covenant set forth in Section 7 and the confidentiality covenant in Section 8.

 

    -6-

     

    

 

C.           
Termination for Cause. In the event that the Employee’s employment with the Company is terminated during
the Employment Period by the Company for Cause, neither the Employee nor the Employee’s beneficiaries or estate will have
any further rights or claims against the Company under this Agreement except the right to receive (i) any unpaid portion of the
Base Salary provided for in Section 3.A, paid through the date of termination; (ii) reimbursement for any expenses for which
the Employee shall not have theretofore been reimbursed as provided in Section 3 hereof; and (iii) the payments provided
under Section 5.E herein. For the avoidance of doubt, an Employee who is terminated by the Company for Cause shall not be entitled
to any Annual Bonus payments or any other payments from the Company following the date of the Employee’s termination other
than as set forth in clauses (i), (ii) and (iii) of this Section 5.C.

 

D.          
Resignation, Death or Disability. In the event that the Employee’s employment with the Company is terminated
during the Employment Period as a result of a Resignation, death or Disability, neither the Employee nor the Employee’s beneficiaries
or estate will have any further rights or claims against the Company under this Agreement except the right to receive (i) any unpaid
portion of the Base Salary provided for in Section 3.A, paid through the date of termination; (ii) reimbursement for any expenses
for which the Employee shall not have theretofore been reimbursed as provided in Section 3 hereof; and (iii) to the extent applicable,
the payments provided under Section 5.E herein. For the avoidance of doubt, an Employee that terminates his or her Employment Period
through a Resignation shall not be entitled to any Annual Bonus payments or any other payments from the Company following the date
of the Employee’s termination other than as set forth in clauses (i), (ii) and (iii) (if applicable) of this Section 5.D.

 

E.           
Other Terminations. If the Employee’s employment is terminated due to any reason other than a termination
by the Company without Cause, a resignation by the Employee with Good Reason within the twelve (12) months following a Change in
Control, or a termination due to the Employee’s death, the Employee will receive an aggregate amount equal to fifty percent
(50%) of the Employee’s highest annualized Base Salary paid in the two years preceding the termination. Such amount shall
be paid out, (i) in equal installments over the nine (9) month period following such termination, in accordance with the Company’s
normal payroll practices, if the termination was not within the twelve (12) months following a Change in Control, and (ii) in a
lump sum, if the termination was within the twelve (12) months following a Change in Control.

 

F.            
Separation Agreement and Release of Claims. The obligation of the Company to make payments or provide benefits
to the Employee under clause (iii) of Section 5.A or Section 5.B shall be conditioned upon the execution and delivery by the Employee
of a general release in which the Employee unconditionally, without any reservation, irrevocably and forever releases and discharges
the Company and its affiliates, and their respective shareholders, members, partners, officers, directors, managers and employees
(collectively, the “Released Parties”) of and from any and all claims, causes of action or demands, that the
Employee then has, or may have, against any of the Released Parties, other than claims arising under this Agreement. Such release
will be in a form substantially similar to that attached hereto as Exhibit A (the “Release”), and will
contain the Employee’s affirmation of his obligation not to compete with the Company as described in Section 6 herein. Any
such payments or benefits following the Employee’s termination are conditioned on and will not be made until (i) such Release
is effective, (ii) if applicable, the expiration of the seven-day period referenced in Section 8 of the Release has occurred, and
(iii) if applicable, the Release is no longer subject to revocation or rescission under any applicable law.

 

    -7-

     

    

 

G.           
Consideration for Non-Competition After Termination. The Employee acknowledges that the cash payments described
in clause (iii)(y) of Section 5.A, clause (iii)(1) of Section 5.B and Section 5.E, the initial stock option grant described in
Section 3.G(i), as well as the other consideration set forth in this Agreement constitute (x) fair and reasonable consideration
for purposes of Section 24L(b)(ii) of Chapter 149 of the Massachusetts General Laws, and (y) mutually agreed upon consideration
for purposes of Section 24L(b)(vii) of Chapter 149 of the Massachusetts General Laws.

 

H.          
Withholding of Taxes. All payments required to be made by the Company to the Employee under this Agreement
shall be subject to the withholding of such amounts, if any, relating to tax, excise tax and other payroll deductions as the Company
may reasonably determine it should withhold pursuant to any applicable law or regulation.

 

I.            
Return of Company Property and Records. Upon any termination of employment for any reason or no reason, or
upon the Company’s request at any time, the Employee shall immediately return to the Company all property of the Company
in the Employee’s possession (including computers, smart phones and other portable electronic devices) and all documents
and other materials in any medium including but not limited to electronic, which relate in any way to the Company, including notebooks,
correspondence, memos, drawings or diagrams, computer files and databases, graphics and formulas, whether prepared by the Employee
or by others and whether required by the Employee’s work or for his or her personal use, whether copies or originals, unless
the Employee first obtains the Company’s written consent to keep such records.

 

6.           
Non-Competition. In consideration of the rights and benefits hereunder, including but not limited
to the payments and benefits referenced in Section 5.G, the Employee agrees that so long as he or she is an employee of the Company
and for a period of twelve (12) months after the date of termination of the Employee’s employment for any reason (the “Restricted
Period”), he or she shall not, without the prior written consent of the Company, own any interest in, control, participate
in, work for, become employed by, or provide services to (whether as an employee, consultant, independent contractor or otherwise)
any individual or entity that competes with the Company in the area of neurodegeneration therapeutics development in the United
States. This Section 6 shall survive the termination of this Agreement.

 

7.           
Non-Solicitation. In consideration of the rights and benefits hereunder, the Employee agrees that
during the Restricted Period, he or she shall not, without the prior written consent of the Company: (i) solicit or encourage any
employee of the Company or its affiliates to leave the employment of the Company or such affiliate; or (ii) solicit or encourage
any client of the Company or any of its affiliates (including any investors in funds managed by the Company or its affiliates)
to cease to do business with the Company or its affiliates. The only exceptions to the restrictions in this paragraph are: (i)
clients (if any) with which Employee had a significant and provable business relationship prior to his/her employment with the
Company, and (ii) where Employee has the express, prior written consent of the Board to be released in whole or part from this
section of the Agreement. This Section 7 shall survive the termination of this Agreement.

 

    -8-

     

    

 

8.           
Confidentiality. Employee agrees that during his or her employment with the Company, he or she
will have access to confidential information and/or proprietary information about the Company and/or its clients, including, but
not limited to, investment strategies, programs or ideas, trade secrets, methods, models, passwords, access to computer files,
financial information and records, forecasts, computer software programs, agreements and/or contracts between the Company and its
respective clients, client contracts, prospective contracts, creative policies and ideas, public relations and public affairs campaigns,
media materials, budgets, practices, concepts, strategies, methods of operation, technical and scientific information, discoveries,
developments, formulas, specifications, know-how, design inventions, marketing and business strategies and financial or business
projects, and information about or received from clients and other companies with which the Company does business. The foregoing
shall be collectively referred to as “Confidential Information.” Any information that is not readily available
to the public shall be considered to be Confidential Information, even if it is not specifically marked as such, unless the Company
advises the Employee otherwise in writing. Such Confidential Information is not readily available to the public and accordingly,
Employee agrees that he or she will not at any time, whether during his or her employment with the Company or thereafter, disclose
to anyone, (other than in furtherance of the business of the Company) any Confidential Information, or utilize such Confidential
Information for his or her own benefit, or for the benefit of third parties. Employee also agrees to preserve and protect the confidentiality
of any third party information similar to the Confidential Information to the same extent, and on the same basis, as the Company’s
Confidential Information. To the extent that any Confidential Information shall become the subject of any search warrant, court
order, lawful subpoena, governmental investigation disclosure request or mandate, or the like (a “Disclosure Request”),
Employee will notify the Company immediately, provide the Company adequate opportunity to oppose such Disclosure Request and reasonably
assist the Company, at no cost to the Employee, in opposing such Disclosure Request or seeking a protective order or such other
limitation on disclosure as may be reasonably requested by the Company. If, after providing the notice and assistance required
by the immediately preceding sentence, Employee is still required by lawful order to disclose any Confidential Information, Employee
shall only disclose such information as is specifically required by such lawful order. The confidentiality protections available
in this Agreement are in addition to, and not exclusive of, any and all other rights, including those provided under copyright,
officer or director fiduciary duties and trade secret and confidential information laws. This confidentiality covenant has no temporal,
geographical or territorial restriction. This Section 8 shall survive the termination of this Agreement.

 

Notwithstanding anything
herein to the contrary, nothing in this Agreement shall (x) prohibit Employee from making reports of possible violations of federal
law or regulation to any governmental agency or entity in accordance with the provisions of and rules promulgated under Section
21F of the Securities Exchange Act of 1934, as amended, or Section 806 of the Sarbanes-Oxley Act of 2002, or of any other whistleblower
protection provisions of federal law or regulation, or (y) require notification or prior approval by the Company of any such report;
provided that, the Employee is not authorized to disclose communications with counsel that were made for the purpose of receiving
legal advice or that contain legal advice or that are protected by the attorney work product or similar privilege.

 

    -9-

     

    

 

DEFEND TRADE SECRETS ACT NOTICE AND RELATED
PROVISIONS: The Defend Trade Secrets Act of 2016 provides as follows: (1) An individual shall not be held criminally or civilly
liable under any federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a federal,
state or local government official or to an attorney and such disclosure is made (a) solely for the purpose of reporting or investigating
a suspected violation of law or (b) in a complaint or other document filed in a lawsuit or other proceeding if such filing is made
under seal. (2) An individual may disclose a trade secret to that individual’s attorney for the purpose of filing a lawsuit
for retaliation by an employer for reporting a suspected violation of law and use the trade secret information in the court proceeding
provided the individual files any document containing the trade secret under seal and the individual does not disclose the trade
secret except pursuant to court order. The Defend Trade Secrets Act also provides that a court enforcing that law may, if a trade
secret is found to have been willfully and maliciously misappropriated, award (a) “exemplary damages” in an amount
of up to two times the amount of damages awarded for actual loss caused by the misappropriation of a trade secret and damages for
unjust enrichment caused by the misappropriation of the trade secret, or a reasonable royalty for the misappropriation, and (b)
reasonable attorneys’ fees against the misappropriating party.

 

9.                 
Intellectual Property Assignment. For the purposes of this Agreement, the “business of the
Company” is defined as the research and development, manufacturing, production, sales, and distributions of small-molecule
kinase inhibitor therapeutics. In the course of Employee’s employment, Employee may develop, conceive, generate, or contribute
to, alone and/or jointly with others, tangible and intangible property including without limitation, inventions, improvements,
business systems, works of authorship, algorithms, software, hardware, know-how, designs, techniques, methods, documentation and
other material, regardless of the form or media in or on which it is stored, some or all of which property may be protected by
patents, copyrights, trade secrets, trade-marks, industrial designs or mask works, that relates to the business of the Company
or to the Company’s actual or demonstrably anticipated research and development, or relates to or incorporates any Confidential
Information, and whether or not made on the Company’s time or premises or using the Company’s resources, equipment,
supplies or facilities, (which tangible and intangible property is collectively referred to in this Agreement as “Proprietary
Property”).

 

All right, title and
interest in and to Confidential Information and Proprietary Property (including, without limitation, the Proprietary Property described
below), belongs to the Company, and Employee has no rights in any such Confidential Information and Proprietary Property. For greater
certainty, all right, title and interest (including without limitation any intellectual property rights) in and to all Confidential
Information and Proprietary Property that Employee may acquire or hold in the course of his or her employment is hereby assigned
to the Company. Employee acknowledges that a Company customer or other third party (referred to in this Agreement as “Customer”)
may, under the terms of its agreement with the Company, own the applicable right, title and interest (including without limitation
any intellectual property rights) in certain Proprietary Property (referred to in this Agreement as “Customer Proprietary
Property”) and Employee agrees to abide by any and all terms of said Customer agreements as they relate to Customer Proprietary
Property and Customer confidential information.

 

    -10-

     

    

 

Employee agrees that
all of the work product that Employee helps to develop while employed with the Company is the exclusive property and Confidential
Information of the Company. Any such work product will be considered to be a work made for hire. Employee agrees to make full disclosure
to the Company of and to properly document any development of Proprietary Property that Employee is involved in, and to provide
written documentation describing such development to the Company, promptly after its creation. At the request and expense of the
Company, both during and after employment, Employee will do all acts necessary and sign all documentation requested by the Company
in order to assign all right, title and interest in and to the Proprietary Property to the Company (or to the applicable Customer,
in relation to Costumer Proprietary Property) and to enable the Company (or the applicable Customer in relation to Customer Proprietary
Property) to register (and to assist the Company to protect and defend its rights in and under any) patents, copyrights, trademarks,
trade secrets, mask works, industrial designs and such other protections as the Company (or such Customer) deems advisable anywhere
in the world. Employee hereby constitutes and appoints the Company and each and every director of the Company as Employee’s
true and lawful attorney with full power of substitution in Employee’s name of and on Employee’s behalf with no restriction
or limitation in that regard, to execute and deliver all such documentation as may be necessary to permit any intellectual property
application to be completed as provided in this Agreement; the foregoing power of attorney shall be irrevocable (to the fullest
extent permitted by law) and is a power coupled with an interest and shall bind Employee and Employee’s heirs, executors
and legal personal representatives.

 

All notes, data, tapes,
reference items, sketches, drawings, memoranda, records, documentation and other material regardless of the form or media in or
on which it is stored, that is in or comes into Employee’s possession or control, and that is in any way obtained, developed,
conceived, generated or contributed to by Employee, alone and/or jointly with others, during or as a result of Employee’s
employment, is and remains Proprietary Property within the meaning of this Agreement.

 

The Company and Employee
agree and understand that the Company claims no right and agrees to release to Employee all rights in any tangible or intangible
property, provided that (i) it was developed by Employee entirely on Employee’s own time, without using the Company’s
or any Customer’s resources, equipment, supplies, facilities, or funds, (ii) it does not relate to the business of the Company
or Customer or to the Company’s or Customer’s actual or demonstrably anticipated research and development, (iii) it
does not relate to or incorporate any Confidential Information or result from any work performed by Employee for the Company or
the Customer; and (iv) it was disclosed by Employee to the Company promptly after its creation.

 

Without limiting the
generality of the foregoing, such property includes the excluded property listed on the attached Exhibit B. If disclosure would
cause Employee to violate any prior confidentiality agreement, Employee understands that Employee is not to list details of such
items in Exhibit B but instead to include a general/generic listing and to inform the Company that details have not been listed
for that reason. If there is no attached Exhibit B, there is no such excluded property.

 

10.         
Cooperation. Following the date of termination or expiration of this Agreement for any reason,
upon the receipt of reasonable notice from the Company (including outside counsel to the Company) or their affiliates, Employee
hereby agrees that he or she will respond and provide information with regard to matters in which he or she has knowledge as a
result of his or her employment and association with the Company. Employee also agrees that he or she will provide reasonable assistance
to the Company and its affiliates and their respective representatives in the defense of any claims that may be made against the
Company or any of its affiliates, and will assist the Company and its affiliates in the prosecution of any claims that may be made
by the Company or any of its affiliates to the extent that such claims may relate to the Employment Period. Employee hereby agrees
to promptly inform the Company (to the extent Employee is legally permitted to do so) if Employee is asked to assist in any investigation
of the Company or any of its affiliates or their actions, regardless of whether a lawsuit or other proceeding has then been filed
with respect to such investigation. This Section 10 shall survive the termination of this Agreement.

 

    -11-

     

    

 

11.         
Enforcement. The Employee acknowledges and agrees that the provisions of this Agreement are reasonable
and necessary for the successful operation of the Company. The Employee further acknowledges that if the Employee breaches any
provision of this Agreement, the Company will suffer irreparable injury. It is therefore agreed that the Company shall have the
right to seek to enjoin any such breach or threatened breach, without posting any bond, if ordered by a court of competent jurisdiction.
The existence of this right to injunctive and other equitable relief shall not limit any other rights or remedies that the Company
may have at law or in equity including, without limitation, the right to monetary, compensatory and punitive damages. If any provision
of this Agreement is determined by a court of competent jurisdiction to be not enforceable in the manner set forth herein, the
Employee and the Company agree that it is the intention of the parties that such provision should be enforceable to the maximum
extent possible under applicable law. Without limiting the foregoing, within seven (7) days after an adjudication that Employee
has breached any provision of Section 6, Section 7 or Section 8, the Employee shall be obligated to repay to the
Company the costs and expenses (including attorney fees) incurred by the Company to obtain such adjudication. This Section 11
shall survive the termination of this Agreement.

 

12.         
Notice. All notices, requests and other communications pursuant to this Agreement shall be in writing
and shall be deemed to have been duly given, if delivered in person or by courier, telegraphed, telexed, electronic mail or by
facsimile transmission or sent by express, registered or certified mail, postage prepaid, addressed as follows:

 

	If to the Company:	
        Chief Executive Officer

        Inhibikase Therapeutics, Inc.

        3350 Riverwood Pkwy SE, Ste 1900

        Atlanta, GA 30339

        Mhwerner@inhibikase.com

	 	 
	If to Employee:	
        at the Employee’s address most recently
        filed with the

        Company

 

Each party may change its address by written
notice in accordance with this Section 12.

 

13.        
Employee Representations. The Employee hereby represents, warrants and covenants to the Company
that the execution and delivery of this Agreement by him or her, and the performance of his or her obligations hereunder are not
in violation of, and do not and will not conflict with or constitute a default under, any of the terms and provisions of any agreement
or instrument to which he or she is subject; and that this Agreement has been duly executed and delivered by him or her and is
a valid and binding obligation in accordance with its terms. Employee hereby acknowledges and confirms that he or she has been
advised to and has had the opportunity to consult with counsel, has carefully read this Agreement, fully understands the terms,
conditions and significance hereof, had ample time to consider and negotiate this Agreement, and has executed this Agreement voluntarily
and knowingly. The Employee acknowledges that he was provided this Agreement upon the earlier of a formal offer of employment or
10 business days prior to the commencement of the Employment Period.

 

    -12-

     

    

 

14.         
Governing Law. This Agreement and all disputes arising hereunder and in connection herewith shall
be governed by and enforceable in accordance with the laws of the Commonwealth of Massachusetts applicable to contracts executed
and performed within such state, without giving effect to the principles of conflict of laws thereof.

 

15.         
Successors and Assigns. This Agreement shall be binding upon the Company’s successors and
assigns and the Company may require any successor or assign to expressly assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform if no such succession or assignment had taken place.
The term “Company” as used herein includes such successors and assigns. The term “successors and assigns”
as used herein means any person or entity that acquires all or substantially all of the Company’s assets and business (including
this Agreement) whether by operation of law or otherwise. This Agreement, with respect to Employee, is for personal services, and
is therefore not assignable.

 

16.         
Severability and Blue-Pencil. To the extent any provision of this Agreement or portion thereof
shall be invalid or unenforceable, it shall be considered deleted therefrom and the remainder of such provision and of this Agreement
shall be unaffected and shall continue in full force and effect. In the event that any of the covenants in this Agreement shall
be determined by any court of competent jurisdiction to be unenforceable by reason of extending for too great a period of time
or over too great a geographical area or by reason of being too extensive in any other respect, it shall be interpreted to extend
over the maximum period of time for which it may be enforceable and to the maximum extent in all other respects as to which it
may be enforceable, and enforced as so interpreted, all as determined by such court in such action. The parties acknowledge the
uncertainty of the law in this respect and expressly stipulate that this Agreement is to be given the construction that renders
its provisions valid and enforceable to the maximum extent (not exceeding its express terms) possible under applicable law.

 

17.         
Expenses. Each of the Company, on the one hand, and the Employee, on the other, will pay all of
its own costs and expenses incident to the negotiation and preparation of this Agreement. If the Company prevails in any proceedings,
legal or equitable, to enforce any obligations under this Agreement, the Company shall also be entitled to recover all costs and
expenses incurred by the Company in connection therewith, including reasonable attorneys’ and accountants’ fees and
disbursements.

 

18.         
Section 409A. The following rules shall apply, to the extent necessary, with respect to distribution
of the payments and benefits, if any, to be provided to the Employee under this Agreement. Subject to the provisions in this Section,
the payments pursuant to this Agreement shall begin only upon the date of Employee’s “separation from service”
(determined as set forth below) which occurs on or after the date of Employee’s termination of employment.

 

    -13-

     

    

 

A.         
This Agreement is intended to comply with or be exempt from Code Section 409A and the parties hereto agree to interpret,
apply and administer this Agreement in the least restrictive manner necessary to comply therewith or be exempt therefrom and without
resulting in any increase in the amounts owed hereunder by the Company.

 

B.           
It is intended that each installment of the payments and benefits provided under this Agreement shall be treated as a separate
 “payment” for purposes of Section 409A of the Internal Revenue Code of 1986, as amended, and the guidance issued thereunder
(“Section 409A”). Neither the Employee nor the Company shall have the right to accelerate or defer the delivery
of any such payments or benefits except to the extent specifically permitted or required by Section 409A.

 

C.           
If, as of the date of the Employee’s “separation from service” from the Company, Employee is a “specified
employee” (within the meaning of Section 409A), then: each installment of the payments and benefits due under this Agreement
that, in accordance with the dates and terms set forth herein, will in all circumstances, regardless of when the separation from
service occurs, be paid within the short-term deferral period (as defined in Section 409A) shall be treated as a short-term deferral
within the meaning of Treasury Regulation Section 1.409A- 1(b)(4) to the maximum extent permissible under Section 409A; and each
installment of the payments and benefits due under this Agreement that are not described in the preceding sentence and that would,
absent this subsection, be paid within the six-month period following Employee’s “separation from service” from
the Company shall not be paid until the date that is six months and one day after such separation from service (or, if earlier,
Employee’s death), with any such installments that are required to be delayed being accumulated during the six-month period
and paid in a lump sum on the date that is six months and one day following Employee’s separation from service and any subsequent
installments, if any, being paid in accordance with the dates and terms set forth herein; provided, however, that the preceding
provisions of this sentence shall not apply to any installment of payments and benefits if and to the maximum extent that such
installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of
the application of Treasury Regulation 1.409A-1(b)(9)(iii) (relating to separation pay upon an involuntary separation from service).
Any installments that qualify for the exception under Treasury Regulation Section 1.409A-1(b)(9)(iii) must be paid no later than
the last day of the second taxable year following the taxable year in which the separation from service occurs.

 

D.         
The determination of whether and when Employee’s separation from service from the Company has occurred shall be made
in a manner consistent with, and based on the presumptions set forth in, Treasury Regulation Section 1.409A-1(h). Solely for purposes
of this Section 18, “Company” shall include all persons with whom the Company would be considered a single employer
as determined under Treasury Regulation Section 1.409A-1(h)(3).

 

E.          
All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the requirements
of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable,
the requirements that (i) any reimbursement is for expenses incurred during Employee’s lifetime (or during a shorter period
of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect
the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense will be made
on or before the last day of the calendar year following the year in which the expense is incurred and (iv) the right to reimbursement
is not subject to set off or liquidation or exchange for any other benefit.

 

    -14-

     

    

 

F.           
If any payments or benefits are conditioned on the execution of a release, and the period within which the Employee may
consider whether to execute the release spans two calendar years, such payments and benefits will not be paid earlier than the
first day of the second calendar year within such period.

 

G.           
Notwithstanding anything herein to the contrary, the Company shall have no liability to Employee or to any other person
if the payments and benefits provided in this Agreement that are intended to be exempt from or compliant with Section 409A are
not so exempt or compliant.

 

19.         
Entire Agreement. This Agreement and the Exhibits attached hereto constitute the entire agreement
by the Company and the Employee with respect to the subject matter hereof and except as specifically provided herein, supersedes
any and all prior agreements or understandings between the Employee and the Company with respect to the subject matter hereof,
whether written or oral, including, but not limited to, that certain Consulting Agreement dated April 1, 2018, between Flagship
Consulting, Inc. and the Company. This Agreement may be amended or modified only by a written instrument executed by the Employee
and the Company.

 

20.         
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument, and in pleading or proving any provision
of this Agreement it shall not be necessary to produce more than one such counterpart. No counterpart shall be effective until
each party has executed at least one counterpart. For the convenience of the parties, facsimile and pdf signatures shall be accepted
as originals.

 

[signature page follows]

 

    -15-

     

    

 

IN WITNESS WHEREOF
the parties have duly executed this Agreement as of the date first written above.

 

	COMPANY:	 
	 	 
	INHIBIKASE
    THERAPEUTICS, INC.	 
	 	 
	By: 	/s/ Milton H. Werner	 
	Name:
    Milton H. Werner, PhD	 
	Title:
    President & CEO	 
	 	 
	 	 
	EMPLOYEE:	 
	 	 
	 	 
	/s/
    Joseph Frattaroli	 
	Joseph
    Frattaroli	 

 

[Signature
page to Employment Agreement]

 

     

     

    

 

EXHIBIT
A

 

FORM OF
GENERAL RELEASE OF ALL CLAIMS

 

This General Release
of All Claims is made as of              , 20__ (“General Release”), by and between INHIBIKASE THERAPEUTICS, INC.
(the “Company”), and                   (the “Employee”).

 

WHEREAS, the Company
and Employee are parties to an Employment Agreement dated as of                , 20__ (the “Employment Agreement”);

 

WHEREAS, the Company
wishes to terminate Employee’s employment with the Company without Cause or the Employee wishes to resign with Good Reason
within twelve months following a Change in Control;

 

WHEREAS, defined terms
not defined in this General Release have the meanings given to them in the Employment Agreement;

 

WHEREAS, the execution
of this General Release is a condition precedent to the payment of certain payments or benefits following the Employee’s
termination, as set forth in Section 5 of the Employment Agreement;

 

WHEREAS, in consideration
for Employee’s signing of this General Release, as well as Employee’s continued compliance with the Employment Agreement,
including without limitation the non-competition and other restrictive covenants contained in Sections 6 through 8 of the Employment
Agreement, the Company will provide such payments or benefits to which the Employee may be entitled pursuant to Section 5 of the
Employment Agreement; and

 

WHEREAS, Employee and
the Company intend that this General Release shall be in full satisfaction of the obligations described in Section 5.F of the Employment
Agreement owed by Employee to the Company.

 

NOW, THEREFORE, in
consideration of the promises and the mutual covenants and agreements herein contained, the Company and Employee agree as follows:

 

1.            
Employee, for himself or herself, Employee’s spouse, heirs, administrators, children, representatives, executors,
successors, assigns, and all other persons claiming through Employee, if any (collectively, “Releasers”), does
hereby release, waive, and forever discharge the Company and each of its respective agents, subsidiaries, parents, affiliates,
related organizations, members, partners, shareholders, employees, officers, directors, attorneys, successors, and assigns (collectively,
the “Releasees”) from, and does fully waive any obligations of Releasees to Releasers for, any and all liability,
actions, charges, causes of action, demands, damages, or claims for relief, remuneration, sums of money, accounts or expenses (including
attorneys’ fees and costs) of any kind whatsoever, whether known or unknown or contingent or absolute, which heretofore has
been or which hereafter may be suffered or sustained, directly or indirectly, by Releasers in consequence of, arising out of, or
in any way relating to: (a) Employee’s employment with the Company or any of its subsidiaries or affiliates; (b) the termination
of Employee’s employment with the Company and any of its subsidiaries or affiliates; (c) the Employment Agreement; or (d)
any events occurring on or prior to the date of this General Release. The foregoing release and discharge, waiver and covenant
not to sue includes, but is not limited to, all claims and any obligations or causes of action arising from such claims, under
common law including wrongful or retaliatory discharge, breach of contract (including but not limited to any claims under the Employment
Agreement and any claims under any equity incentive arrangements between Employee, on the one hand, and the Company or any of its
subsidiaries or affiliates, on the other hand) and any action arising in tort including libel, slander, defamation or intentional
infliction of emotional distress, and claims under any federal, state or local statute including the Age Discrimination in Employment
Act (“ADEA”), Title VII of the Civil Rights Act of 1964 (“Title VII”), the Civil Rights Act
of 1866 and 1871 (42 U.S.C. § 1981), the National Labor Relations Act, the Fair Labor Standards Act, the Employee Retirement
Income Security Act, the Americans with Disabilities Act of 1990 (“ADA”), the Rehabilitation Act of 1973, the
discrimination or employment laws of any state or municipality, and/or any claims under any express or implied contract which Releasers
may claim existed with Releasees. This also includes a release of any claims for wrongful discharge and all claims for alleged
physical or personal injury, emotional distress relating to or arising out of Employee’s employment with the Company or any
of its subsidiaries or affiliates or the termination of that employment; and any claims under the Worker Adjustment and Retraining
Notification Act or any similar law, which requires, among other things, that advance notice be given of certain work force reductions.
This release and waiver does not apply to: (i) any right to indemnification now existing under the Company’s governing documents;
(ii) any rights to the receipt of employee benefits under any employee benefit plan which vested on or prior to the date of this
General Release; (iii) the right to receive certain payments or benefits under Section 5 of the Employment Agreement; and (iv)
the right to continuation health coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act.

 

    -1-

     

    

 

2.           
Excluded from this General Release and waiver are any claims which cannot be waived by law, including but not limited to
the right to participate in an investigation conducted by certain government agencies. Employee does, however, waive Employee’s
right to any monetary recovery should any agency (such as the Equal Employment Opportunity Commission) pursue any claims on Employee’s
behalf. Employee represents and warrants that Employee has not filed any complaint, charge, or lawsuit against the Releasees with
any government agency or any court.

 

3.           
Employee agrees never to seek personal recovery from Releasees in any forum for any claim covered by the above waiver and
release language. If Employee violates this General Release by suing Releasees, Employee shall be liable to the Releasees for their
reasonable attorneys’ fees and other litigation costs incurred in defending against such a suit and Employee shall reimburse
the Releasees for their costs and expenses. Nothing in this General Release is intended to reflect any party’s belief that
Employee’s waiver of claims under ADEA is invalid or unenforceable, it being the intent of the parties that such claims are
waived.

 

4.           
To the extent, if any, that Employee has rights in any invention, improvement, discovery, process, program, product or system
developed by Employee during his or her employment with the Company, Employee hereby irrevocably transfers, assigns and conveys
such rights to the Company and agrees that the Company shall be and remain the sole and exclusive owner of all right, title and
interest in and to any such invention, improvement, discovery, process, program, product or system, including, but not limited
to, all patent, copyright, trade secret and other proprietary rights therein that may be secured in any place under laws now or
hereinafter in effect.

 

    -2-

     

    

 

5.           
Employee agrees that neither this General Release, nor the furnishing of the consideration for this General Release, shall
be deemed or construed at any time to be an admission by the Company, any Releasees or Employee of any improper or unlawful conduct.

 

6.            
Employee acknowledges and recites that:

 

(a)               
Employee has executed this General Release knowingly and voluntarily;

 

(b)               
Employee has read and understands this General Release in its entirety;

 

(c)               
Employee has been advised and directed orally and in writing (and this subparagraph (c) constitutes such written direction)
to seek legal counsel and any other advice Employee wishes with respect to the terms of this General Release before executing it;

 

(d)               
By execution of this General Release, Employee expressly waives any and all claims relating to age discrimination and disability
or handicap discrimination and releases any rights he may have under Title VII, ADEA, the ADA, and/or any State or local laws;

 

(e)               
Employee hereby acknowledges that the waiver of his or her rights and/or claims existing under Title VII, ADEA and ADA and/or
any State or local laws is in consideration for payments or benefits to which the Employee is entitled under Section 5 of the Employment
Agreement;

 

(f)                
Employee’s execution of this General Release has not been forced by any employee or agent of the Company, and Employee
has had an opportunity to negotiate about the terms of this General Release; and

 

(g)              
Employee has been offered twenty-one (21) calendar days after receipt of this General Release to consider its terms before
executing it. I

 

7.            
This General Release shall be governed by the internal laws (and not the choice of laws) of the Commonwealth of Massachusetts,
except for the application of pre-emptive Federal law.

 

8.           
Employee shall have seven (7) days from the date Employee executes this General Release to revoke Employee’s waiver
of any ADEA claims by providing written notice of the revocation to the Company. In the event that Employee revokes this General
Release, the Company shall have no obligation to make any payments or benefits under Section 5 of the Employment Agreement that
were expressly conditioned on the execution of this release.

 

 

 

I In the
event Company determines that Employee’s termination constitutes “an exit incentive or other employment termination
program offered to a group or class of employees” under the ADEA, Company will provide Employee with: (1) 45 days to consider
the General Release; and (2) the disclosure schedules required for an effective release under the ADEA.

 

    -3-

     

    

 

9.           
Nothing in this General Release shall relieve Employee of his or her obligations under Sections 6 (Non-Competition), 7 (Non-Solicitation)
or 8 (Confidentiality) of the Employment Agreement and the Employee hereby agrees to comply with his or her obligations as set
forth in Section 6, 7, and 8 of the Employment Agreement.

 

10.         
If this General Release is found to be invalid or unenforceable in any way, the Employee shall execute and deliver to the
Company a revised release which will effectuate Employee’s intention to release the Releasees, as set forth herein, to the
maximum extent permitted by law.

 

PLEASE READ
THIS AGREEMENT CAREFULLY. IT CONTAINS A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.

 

	Date:	 	 	 
	 	 	Employee

 

    -4-

     

    

 

EXHIBIT
B

 

EXCLUDED
PROPERTY FROM INTELLECTUAL PROPERTY ASSIGNMENT

 

    -1-Exhibit 10.9

 

INHIBIKASE THERAPEUTICS, INC.

  

INDEMNIFICATION AGREEMENT

 

     

     

    

 

INDEMNIFICATION
AGREEMENT

 

THIS INDEMNIFICATION
AGREEMENT (the “Agreement”) is made and entered into as of [●], 2020 between Inhibikase Therapeutics, Inc.,
a Delaware corporation (the “Company”), and [●] (“Indemnitee”).

 

RECITALS

 

WHEREAS, highly
competent persons have become more reluctant to serve corporations as directors or in other capacities unless they are provided
with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them
arising out of their service to and activities on behalf of the corporation;

 

WHEREAS, the
Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons
serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary
and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given
current market conditions and trends, such insurance may not be available to it on terms that the company considers to be commercially
reasonable or, if available to it on commercially reasonable terms during some period of time, may be available to it in the future
only at higher premiums and with more exclusions. At the same time, directors, officers, and other persons in service to corporations
or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other things,
matters that traditionally would have been brought only against the Company or business enterprise itself. The Amended and Restated
Certificate of Incorporation of the Company (as the same may be amended or restated from time to time, the “Certificate
of Incorporation”) and the Company’s Bylaws (as the same may be amended or restated from time to time, the “Bylaws”)
require indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant
to the General Corporation Law of the State of Delaware (as the same may be amended from time to time, the “DGCL”).
The Bylaws and Certificate of Incorporation and the DGCL expressly provide that the indemnification provisions set forth therein
are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers
and other persons with respect to indemnification;

 

WHEREAS, the
uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons;

 

WHEREAS, the
Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests
of the Company’s stockholders and that the Company should act to assure such persons that there will be increased certainty
of such protection in the future;

 

WHEREAS, it
is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company
free from undue concern that they will not be so indemnified;

 

    1

     

    

 

WHEREAS, this
Agreement is a supplement to and in furtherance of the Bylaws and Certificate of Incorporation of the Company and any resolutions
adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

WHEREAS, Indemnitee
does not regard the protection available under the Company’s Bylaws and Certificate of Incorporation and insurance as adequate
in the present circumstances, and may not be willing to serve as an officer or director without adequate protection, and the Company
desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service
for or on behalf of the Company on the condition that Indemnitee be so indemnified; and

 

NOW, THEREFORE,
in consideration of Indemnitee’s agreement to serve as an officer or director from and after the date hereof, the parties
hereto agree as follows:

 

1.            Indemnity
of Indemnitee. The Company hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent permitted by law,
as such may be amended from time to time. In furtherance of the foregoing indemnification, and without limiting the generality
thereof.

 

(a)            Proceedings
Other Than Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided
in this Section l(a) if, by reason of Indemnitee’s Corporate Status (as hereinafter defined), Indemnitee
is, or is threatened to be made, a party to or participant in any Proceeding (as hereinafter defined) other than a Proceeding by
or in the right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses
(as hereinafter defined), judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee,
or on Indemnitee’s behalf, in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted
in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and
with respect to any criminal Proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful.

 

(b)            Proceedings
by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided in this Section 1(b) if,
by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in
any Proceeding brought by or in the right of the Company. Pursuant to this Section 1(b), Indemnitee shall be indemnified
against all Expenses actually and reasonably incurred by Indemnitee, or on Indemnitee’s behalf, in connection with such Proceeding
if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company; provided, however, if applicable law so provides, no indemnification against such Expenses shall
be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged to be liable
to the Company unless and to the extent that the Court of Chancery of the State of Delaware shall determine that such indemnification
may be made.

 

    2

     

    

 

(c)            Indemnification
for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement, to the extent
that Indemnitee is, by reason of Indemnitee’s Corporate Status, a party to and is successful, on the merits or otherwise,
in any Proceeding, Indemnitee shall be indemnified to the maximum extent permitted by law, as such may be amended from time
to time, against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith.
If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but
less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually
and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with each successfully resolved claim, issue
or matter. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding
by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

 

2.            Additional
Indemnity. In addition to, and without regard to any limitations on, the indemnification provided for in Section 1
of this Agreement, the Company shall and hereby does indemnify and hold harmless Indemnitee against all Expenses, judgments, penalties,
fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf if, by reason
of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding
(including a Proceeding by or in the right of the Company), including, without limitation, all liability arising out of the negligence
or active or passive wrongdoing of Indemnitee. The only limitation that shall exist upon the Company’s obligations pursuant
to this Agreement shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined
(under the procedures, and subject to the presumptions, set forth in Sections 6 and 7 hereof) to be unlawful.

 

3.            Contribution.

 

(a)            Whether
or not the indemnification provided in Sections 1 and 2 hereof is available, in respect of any threatened, pending
or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), to the fullest extent permitted under applicable law, the Company shall pay, in the first instance, the entire
amount of any judgment or settlement of such action, suit or proceeding without requiring Indemnitee to contribute to such payment
and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Company shall not
enter into any settlement of any action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be
if joined in such action, suit or proceeding) unless such settlement provides for a full and final release of all claims asserted
against Indemnitee.

 

(b)            Without
diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee
shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action,
suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),
the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably
incurred and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all officers, directors
or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction or events from which such action,
suit or proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may,
to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers,
directors or employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such
action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the transaction or events that
resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations which applicable
law may require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other
than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one
hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions
were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and
the degree to which their conduct is active or passive.

 

    3

     

    

 

(c)            To
the fullest extent permitted under applicable law, the Company hereby agrees to fully indemnify and hold Indemnitee harmless from
any claims of contribution which may be brought by officers, directors, or employees of the Company, other than Indemnitee, who
may be jointly liable with Indemnitee.

 

(d)            To
the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee
for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee,
whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses actually and
reasonably incurred, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as
is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative
benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such
Proceeding and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee
in connection with such event(s) and/or transaction(s).

 

4.            Indemnification
for Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason
of Indemnitee’s Corporate Status, a witness, or is made (or asked) to respond to discovery requests, in any Proceeding to
which Indemnitee is not a party, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by
Indemnitee or on Indemnitee’s behalf in connection therewith.

 

5.            Advancement
of Expenses. Notwithstanding any other provision of this Agreement, the Company shall advance all Expenses actually and reasonably
incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee’s Corporate Status within
thirty (30) days after the receipt by the Company of a statement or statements from Indemnitee requesting such advance or advances
from time to time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably
evidence the Expenses actually and reasonably incurred by Indemnitee and shall include or be preceded or accompanied by a written
undertaking by or on behalf of Indemnitee to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is
not entitled to be indemnified against such Expenses. Any advances and undertakings to repay pursuant to this Section 5
shall be unsecured and interest free.

 

    4

     

    

 

6.            Procedures
and Presumptions for Determination of Entitlement to Indemnification. It is the intent of this Agreement to secure for Indemnitee
rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the State of Delaware. Accordingly,
the parties agree that the following procedures and presumptions shall apply in the event of any question as to whether Indemnitee
is entitled to indemnification under this Agreement:

 

(a)            To
obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or
therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine
whether and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt
of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding
the foregoing, any failure of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion,
shall not relieve the Company of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually
and materially prejudices the interests of the Company.

 

(b)            Upon
written request by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination
with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods,
which shall be at the election of the Board (1) by a majority vote of the disinterested directors, even though less than a
quorum, (2) by a committee of disinterested directors designated by a majority vote of the disinterested directors, even though
less than a quorum, (3) if there are no disinterested directors or if the disinterested directors so direct, by independent
legal counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (4) if so directed by
the Board, by the stockholders of the Company. For purposes hereof, disinterested directors are those members of the Board who
are not parties to the action, suit or proceeding in respect of which indemnification is sought by Indemnitee.

 

(c)            If
the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 6(b) hereof,
the Independent Counsel shall be selected as provided in this Section 6(c). The Independent Counsel shall be selected
by the Board and written notice of such selection shall be given to Indemnitee. Indemnitee may, within ten (10) days after
such written notice of selection shall have been given, deliver to the Company a written objection to such selection; provided,
however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements
of “Independent Counsel” as defined in Section 13 of this Agreement, and the objection shall set
forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall
act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not serve as
Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit.
If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to Section 6(a) hereof,
no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Court of
Chancery of the State of Delaware or other court of competent jurisdiction for resolution of any objection which shall have been
made by Indemnitee to the Board’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a
person selected by the court or by such other person as the court shall designate, and the person with respect to whom all objections
are so resolved or the person so appointed shall act as Independent Counsel under Section 6(b) hereof. The Company
shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection with
acting pursuant to Section 6(b) hereof, and the Company shall pay all reasonable fees and expenses incident to
the procedures of this Section 6(c), regardless of the manner in which such Independent Counsel was selected or appointed.

 

    5

     

    

 

(d)            In
making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination
shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption
shall have the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company
(including by its directors or independent legal counsel) to have made a determination prior to the commencement of any action
pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard
of conduct, nor an actual determination by the Company (including by its directors or independent legal counsel) that Indemnitee
has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not
met the applicable standard of conduct.

 

(e)            To
the fullest extent permitted by applicable law, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s
action is based on the records or books of account of the Enterprise (as hereinafter defined), including financial statements,
or on information supplied to Indemnitee by the officers of the Enterprise in the course of their duties, or on the advice of legal
counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public
accountant or by an appraiser or other expert selected with reasonable care by the Enterprise. In addition, the knowledge and/or
actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed to Indemnitee for
purposes of determining the right to indemnification under this Agreement. Whether or not the foregoing provisions of this Section 6(e) are
satisfied, it shall in any event be presumed that Indemnitee has at all times acted in good faith and in a manner Indemnitee reasonably
believed to be in or not opposed to the best interests of the Company. Anyone seeking to overcome this presumption shall have the
burden of proof and the burden of persuasion by clear and convincing evidence.

 

(f)            If
the person, persons or entity empowered or selected under Section 6 to determine whether Indemnitee is entitled to
indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor,
the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by applicable law, be deemed
to have been made and Indemnitee shall be entitled to such indemnification absent (i) a misstatement by Indemnitee of a material
fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection
with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law; provided,
however, that such sixty (60) day period may be extended for a reasonable time, not to exceed an additional thirty (30)
days, if the person, persons or entity making such determination with respect to entitlement to indemnification in good faith requires
such additional time to obtain or evaluate documentation and/or information relating thereto; and provided further, that
the foregoing provisions of this Section 6(f) shall not apply if the determination of entitlement to indemnification
is to be made by the stockholders pursuant to Section 6(b) of this Agreement and if (A) within fifteen (15)
days after receipt by the Company of the request for such determination, the Board or the Disinterested Directors, if appropriate,
resolve to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within
seventy five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders
is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such
purpose within sixty (60) days after having been so called and such determination is made thereat.

 

    6

     

    

 

(g)            Indemnitee
shall reasonably cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement
to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or
information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and
reasonably necessary to such determination. Any Independent Counsel, member of the Board or stockholder of the Company shall act
reasonably and in good faith in making a determination regarding Indemnitee’s entitlement to indemnification under this Agreement.
Any costs or expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with
the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to
Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

 

(h)            The
Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to
avoid expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee
is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation, settlement
of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee
has been successful on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption
shall have the burden of proof and the burden of persuasion by clear and convincing evidence.

 

(i)            The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a
plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely
affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner
which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal
Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee’s conduct was unlawful.

 

7.            Remedies
of Indemnitee.

 

(a)            In
the event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is not entitled
to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5
of this Agreement, (iii) no determination of entitlement to indemnification is made pursuant to Section 6(b) of
this Agreement within ninety (90) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification
is not made pursuant to this Agreement within ten (10) days after receipt by the Company of a written request therefor, or
(v) payment of indemnification is not made within ten (10) days after a determination has been made that Indemnitee is
entitled to indemnification or such determination is deemed to have been made pursuant to Section 6 of this Agreement,
or (vi) the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable,
or institutes any litigation or other action or Proceeding designed to deny or to recover from, Indemnitee the benefits provided
or intended to be provided to Indemnitee hereunder, Indemnitee shall be entitled to an adjudication in an appropriate court
of the State of Delaware, or in any other court of competent jurisdiction, of Indemnitee’s entitlement to such indemnification.
Indemnitee shall commence such proceeding seeking an adjudication within one hundred eighty (180) days following the date on which
Indemnitee first has the right to commence such proceeding pursuant to this Section 7(a). The Company shall not oppose
Indemnitee’s right to seek any such adjudication.

 

    7

     

    

 

(b)            In
the event that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee
is not entitled to indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted
in all respects as a de novo trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination
under Section 6(b).

 

(c)            If
a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to
indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section 7,
absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
misstatement not materially misleading in connection with the application for indemnification, or (ii) a prohibition of such
indemnification under applicable law.

 

(d)            In
the event that Indemnitee, pursuant to this Section 7, seeks a judicial adjudication of Indemnitee’s rights under,
or to recover damages for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance
policies maintained by the Company, the Company shall pay on Indemnitee’s behalf, in advance, any and all expenses (of the
types described in the definition of Expenses in Section 13 of this Agreement) actually and reasonably incurred by
Indemnitee in such judicial adjudication, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification,
advancement of expenses or insurance recovery.

 

(e)            The
Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this Section 7 that the
procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that
the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses
actually and reasonably incurred and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company
of a written request therefore) advance, to the extent not prohibited by law, such expenses to Indemnitee, which are actually and
reasonably incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses
from the Company under this Agreement or under any directors’ and officers’ liability insurance policies maintained
by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of
Expenses or insurance recovery, as the case may be.

 

(f)            Notwithstanding
anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be
required to be made prior to the final disposition of the Proceeding.

 

    8

     

    

 

8.            Non-Exclusivity;
Survival of Rights; Insurance; Primacy of Indemnification; Subrogation.

 

(a)            The
rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may
at any time be entitled under applicable law, the Certificate of Incorporation, the By-laws, any agreement, a vote of stockholders,
a resolution of directors of the Company, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision
hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee
in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in the DGCL,
whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the Certificate
of Incorporation, By-laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement
the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right
or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder
or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or
otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

 

(b)            To
the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees,
or agents or fiduciaries of the Company or of any other corporation, partnership, limited liability company, joint venture, trust,
employee benefit plan or other enterprise that such person serves at the request of the Company, Indemnitee shall be covered
by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any director,
officer, employee, agent or fiduciary under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant
to the terms hereof, the Company has directors’ and officers’ liability insurance in effect, the Company shall give
prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective
policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee,
all amounts payable as a result of such proceeding in accordance with the terms of such policies.

 

(c)            In
the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights
of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including
execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

 

(d)            The
Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the
extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise
and has no obligation to return or repay such funds.

 

(e)            The
Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the
Company as a director, officer, employee or agent of any other corporation, partnership, limited liability company, joint venture,
trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification
or advancement of expenses from such other corporation, partnership, limited liability company, joint venture, trust, employee
benefit plan or other enterprise.

 

    9

     

    

 

9.            Exception
to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this
Agreement to make any indemnity in connection with any claim made against Indemnitee:

 

(a)            for
which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except
with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; or

 

(b)            for
an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within
the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state
statutory law or common law; or

 

(c)            in
connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of
any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless
(i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, or (ii) the Company
provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.

 

10.          Duration
of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is
an officer or director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent
of another corporation, partnership, limited liability company, joint venture, trust or other enterprise) and shall continue thereafter
so long as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under Section 7 hereof) by reason
of Indemnitee’s Corporate Status, whether or not Indemnitee is acting or serving in any such capacity at the time any liability
or expense is incurred for which indemnification can be provided under this Agreement. This Agreement shall be binding upon and
inure to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect
successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company),
assigns, spouses, heirs, executors and personal and legal representatives.

 

11.          Security.
To the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide security
to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral.
Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of Indemnitee.

 

12.         Enforcement.

 

(a)            The
Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby
in order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee is
relying upon this Agreement in serving as an officer or director of the Company.

 

    10

     

    

 

(b)            This
Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes
all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter
hereof.

 

(c)            The
Company shall not seek from a court, or agree to, a “bar order” which would have the effect of prohibiting or limiting
Indemnitee’s rights to receive advancement of expenses under this Agreement.

 

13.          Definitions.
For purposes of this Agreement:

 

(a)            “Corporate
Status” describes the status of a person who is or was a director, officer, employee, agent or fiduciary of the Company
or of any other corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise
that such person is or was serving at the express written request of the Company.

 

(b)            “Disinterested
Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification
is sought by Indemnitee.

 

(c)            “Enterprise”
shall mean the Company and any other corporation, partnership, limited liability company, joint venture, trust, employee benefit
plan or other enterprise that Indemnitee is or was serving at the express written request of the Company as a director, officer,
employee, agent or fiduciary.

 

(d)            “Expenses”
shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel
expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all other disbursements
or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating,
participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting to, a request to provide discovery
in any Proceeding. Expenses also shall include Expenses actually and reasonably incurred in connection with any appeal resulting
from any Proceeding and any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt
of any payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost
bond, supersede as bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement
by Indemnitee or the amount of judgments or fines against Indemnitee.

 

(e)            “Independent
Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently
is, nor in the past five years has been, retained to represent (i) the Company or Indemnitee in any matter material to either
such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar
indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.
Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee
in an action to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees of the
Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and
damages arising out of or relating to this Agreement or its engagement pursuant hereto.

 

    11

     

    

 

(f)            “Proceeding”
includes any threatened, pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation,
inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought by or in the right of
the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is or will be involved
as a party or otherwise, by reason of Indemnitee’s Corporate Status, by reason of any action taken by Indemnitee or of any
inaction on Indemnitee’s part while acting in Indemnitee’s Corporate Status; in each case whether or not Indemnitee
is acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification can be provided
under this Agreement; including one pending on or before the date of this Agreement, but excluding one initiated by Indemnitee
pursuant to Section 7 of this Agreement to enforce Indemnitee’s rights under this Agreement.

 

14.          Severability.
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.
Further, the invalidity or unenforceability of any provision hereof as to either Indemnitee or Appointing Stockholder shall in
no way affect the validity or enforceability of any provision hereof as to the other. Without limiting the generality of the foregoing,
this Agreement is intended to confer upon Indemnitee and Appointing Stockholder indemnification rights to the fullest extent permitted
by applicable laws. In the event any provision hereof conflicts with any applicable law, such provision shall be deemed modified,
consistent with the aforementioned intent, to the extent necessary to resolve such conflict.

 

15.          Modification
and Waiver. No supplement, modification, termination or amendment of this Agreement shall be binding unless executed in writing
by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver
of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 

16.          Notice
By Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise receiving any
summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may
be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of any obligation
which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially
prejudices the Company.

 

17.          Notice
by Company. If Indemnitee is the subject of, or is, to the knowledge of the Company, implicated in any way during an investigation,
whether formal or informal, that is related to Indemnitee’s Corporate Status and that reasonably could lead to a Proceeding
for which indemnification can be provided under this Agreement, the Company shall notify Indemnitee of such investigation and shall
share (to the extent legally permissible) with Indemnitee any information it has provided to any third parties concerning the investigation
(“Shared Information”). By executing this Agreement, Indemnitee agrees that such Shared Information is
material non-public information that Indemnitee is obligated to hold in confidence and may not disclose publicly; provided,
however, that Indemnitee may use the Shared Information and disclose such Shared Information to Indemnitee’s legal
counsel and third parties, in each case solely in connection with defending Indemnitee from legal liability.

 

    12

     

    

 

18.          Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile
if sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days
after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day
after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt.
All communications shall be sent:

 

(a)            To
Indemnitee at the address set forth below Indemnitee signature hereto.

 

(b)            To
the Company at:

 

Inhibikase Therapeutics, Inc.

3350 Riverwood Parkway SE, Suite 1900

Atlanta, GA 30339

Attention: Chief Financial Officer

 

or to such other address
as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be. If notice is given
to the Company, a copy shall also be sent to (which copy shall not constitute notice): Pepper Hamilton LLP, Attention: Merrill
Kraines, 620 Eighth Avenue, 37th Floor, New York, NY 10018-1405.

 

19.          Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same the same instrument. Counterparts may be delivered
via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000,
e.g., www.docusign.com) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

20.          Headings.
The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of
this Agreement or to affect the construction thereof.

 

21.          Governing
Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed
and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. The Company and
Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection
with this Agreement shall be brought only in the Chancery Court of the State of Delaware (the “Delaware Court”),
and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent
to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection
with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court,
and (iv) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court
has been brought in an improper or inconvenient forum.

 

[Signature Page Follows]

 

    13

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Indemnification Agreement on and as of the day and year first above written.

 

	 	THE COMPANY:
	 	 
	 	INHIBIKASE THERAPEUTICS, INC.
	 	 
	 	By:	                               
	 	Name:
	 	Title:

 

[Signature Page to
Indemnification Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Indemnification Agreement on and as of the day and year first above written.

 

	 	INDEMNITEE:
	 	 
	 	Name:
	 	 
	 	Address:

 

[Signature
Page to Indemnification Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]